Genome-edited baby claim provokes international outcry
@article{Cyranoski2018GenomeeditedBC, title={Genome-edited baby claim provokes international outcry}, author={David Cyranoski and Heidi Ledford}, journal={Nature}, year={2018}, volume={563}, pages={607-608} }
The startling announcement by a Chinese scientist represents a controversial leap in the use of genome editing.The startling announcement by a Chinese scientist represents a controversial leap in the use of genome-editing.
156 Citations
International Reporting Mechanism for Unethical Germline Gene Editing Experiments Is Needed.
- EducationTrends in biotechnology
- 2020
An Exclusive Interview With CRISPR.
- MedicineAMA journal of ethics
- 2019
This article chronicles a didactic encounter between an ethics-minded physician-scientist and a personified genome editing technology called clustered regularly interspaced short palindromic repeats…
Editing the Gene Editing Debate: Reassessing the Normative Discussions on Emerging Genetic Technologies
- Psychology
- 2019
The revolutionary potential of the CRISPR-Cas9 gene editing technique has created a resurgence in enthusiasm and concern in genetic research perhaps not seen since the mapping of the human genome at…
CRISPR’d babies: human germline genome editing in the ‘He Jiankui affair’*
- ArtJournal of law and the biosciences
- 2019
This article is an effort to provide some deep context for the He Jiankui affair and to begin analyzing it, including a detailed narrative of the revelation of the He experiment and its fallout.
Governance of gene editing in South Africa: Towards addressing the ethico-legal hiatus
- Medicine
- 2020
The First South African Conference on Gene Editing brought together local and international experts at the end of November 2019 to discuss and debate issues and to inform appropriate and relevant recommendations.
Legal framework for gene editing in human genome “ World ’ s First Mutant twins by China ”
- Biology
- 2019
Whether the legislation that specifically address the issue of Assistive Reproductive Technology research and Human Embryo Stem Cell research are sufficient and provide sustainable legal framework that is pertinent to the regulatory control of this research in China is addressed.
Gene Editing Expands the Donor Pool for CCR5-Negative Stem Cell Transplants.
- Biology, MedicineCell stem cell
- 2019
Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.
- MedicineThe CRISPR journal
- 2019
It is found SCD stakeholders hold a nuanced view of HGE, and assuming the technology is shown to be safe and effective, they are just as supportive of H GE as genetics professionals, but more supportive than the general public.